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Background. Stenosis of hemodialysis arteriovenous grafts
is usually focal and caused by the proliferation of vascular
smooth muscle cells (SMCs). External radiation of the graft is a
potential strategy to prevent stenosis; however, the relative re-
sponsiveness of arterial and venous SMCs to radiation is un-
known.
Methods. Human aortic and saphenous vein SMCs were cul-
tured in a medium containing growth factors and serum and
treated with 0 to 50 Gy in a c irradiator. At 2 to 20 days post-
irradiation, cell counting, methylthiazoletetrazolium dye reduc-
tion, [3H]-thymidine uptake, and bromodeoxyuridine (BrdU)
incorporation assays were performed.
Results. All assays showed that 1 to 50 Gy inhibited the pro-
liferation of both aortic and venous SMCs in a dose-dependent
manner. Importantly, venous cells were less susceptible to radi-
ation in all assays, compared to aortic cells. At day 10, 1 to 50
Gy of radiation inhibited the increase in the number of aortic
cells by 24% to 66% and venous cells by 8% to 25% (P < 0.01)
(aortic vs. venous). The differences between aortic and venous
cells varied among different assays and were most pronounced
in the BrdU assay.
Conclusion. Inasmuch as myointimal hyperplasia occurs at
both arterial and venous anastomoses, future strategies using ra-
diation to prevent hemodialysis vascular access stenosis should
take these differences into consideration.
Vascular access failure is a common problem in chronic
hemodialysis patients, leading to substantial morbidity
and medical expenses [1]. Failure of the synthetic arte-
riovenous graft is often due to stenosis at the venous,
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and to a lesser extent the arterial, anastomosis as a re-
sult of myointimal hyperplasia, which is largely prolif-
eration of vascular smooth muscle cells (SMCs) with
matrix deposition [2]. Although balloon angioplasty has
become an accepted treatment for graft stenosis, recur-
rence rates following this procedure are high, reported
to be 37% to 62% at 6 months [3–5]. This is partly
because balloon angioplasty induces injury to the ves-
sel wall, which leads to cell proliferation and a vicious
cycle. Therefore, inhibiting vascular SMC proliferation
is a better approach to prevent myointimal hyperpla-
sia and graft stenosis. One potential approach is ionizing
radiation.
Ionizing radiation induces DNA damage, which leads
to cell death. At sublethal doses, it appears to induce the
expression of both early- and late-responding genes asso-
ciated with growth control [6–8]. Further, radiation may
induce apoptosis and inhibition of normal cell cycle pro-
gression in various cell types [6, 7, 9]. Proliferating SMCs
may be particularly susceptible to the effects of ioniz-
ing radiation, such as those found in intimal hyperplastic
lesions in hemodialysis vascular access. Several reports
have shown that radiation inhibits arterial SMC prolif-
eration in culture and in whole animals [8–12]. Little is
known, however, about the effect of radiation on cul-
tured venous SMCs, even though most stenotic lesions
are found at the venous anastomosis of synthetic vascu-
lar grafts and the literature accumulated in the last few
years have demonstrated that arterial SMCs and venous
SMCs are phenotypically different from each other [13–
16]. Our recent study has further shown that human aortic
SMCs are more resistant to antiproliferative drugs than
venous SMCs [17]. In the present study, we examined the
differences in susceptibility to the inhibitory effects of
c radiation between human aortic and venous SMCs in
culture.
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METHODS
Materials
Human aortic and saphenous vein SMCs and SMC
Growth Medium-2 Bullet Kit were purchased from Clo-
netics (Walkersville, MD, USA). The medium contained
5 lg/mL insulin, 0.5 ng/mL human recombinant epider-
mal growth factor (EGF), 2 ng/mL human recombinant
fibroblast growth factor (FGF), 50 lg/mL gentamicin,
50 ng/mL amphotericin-B, and 10% fetal bovine serum
(FBS). Fluorescein isothiocyanate (FITC)-conjugated
antihuman smooth muscle actin (SMA) was purchased
from Sigma-Aldrich (St. Louis, MO, USA). Rabbit an-
tihuman von Willebrand factor was purchased from
Serotec (Raleigh, NC, USA). FITC-conjugated antirab-
bit IgG used as the second antibody for von Willebrand
factor detection was purchased from Sigma-Aldrich.
Methylthiazoletetrazolium (MTT) was purchased from
Calbiochem (La Jolla, CA, USA). The bromodeoxyuri-
dine (BrdU)-labeled DNA colorimetric enzyme-linked
immunosorbent assay (ELISA) kit and [3H]-thymidine
were purchased from Amersham (Piscataway, NJ, USA).
Cell culture
Cells were cultured at 37◦C in a humidified 5% CO2
incubator. SMCs were identified by their typical morphol-
ogy under light microscopy, positive staining with FITC-
conjugated anti-SMA and negative staining with anti-von
Willebrand factor. Cells from passages 7 to 10 were used
in the experiments, similar to those used in our recent
studies on antiproliferative drugs [17].
c Irradiation
Cells were harvested from a T-75 culture flask using
digestion with trypsin. The cells were transferred to a
50 mL culture tube, centrifuged and resuspended in the
SMC Growth Medium-2. Suspensions of various concen-
trations of cells were then irradiated with a single dose of
1, 5, 10, 20, or 50 Gy in a Mark 1-30137 Cs irradiator (JL
Shepherd and Associates, San Fernando, CA, USA) de-
livering 7.3 Gy/min at room temperature. Irradiated cells
were seeded onto 96-well culture plates at 1 × 104 cells
per well and incubated at 37◦C in 5% CO2. After the cells
became adherent, the medium was changed every 2 to 3
days.
Cell activity assay
Four different assays were used to assess the effect of
radiation on the vascular SMCs. At 2, 5, 10, 15, and 20
days post-irradiation, the cells were harvested from the
culture plates by digestion with trypsin and the number
of cells was determined using a Coulter counter (Beck-
man Coulter, Inc., Allendale, NJ, USA). In addition, the
mitochondrial dehydrogenase activity of the cells was as-
sessed using the MTT dye reduction assay [18, 19]. In
brief, the cells were incubated with 25 lL of MTT so-
lution (0.5 mg/mL) for 4 hours at 37◦C. The resultant
formazan product was solubilized in 100 lL of 0.1 N HCl
and isopropyl alcohol. The absorbance was measured us-
ing a microtiter plate reader at 540 nm test wave length
and at 690 nm wave length as reference. The results are
presented as absorbance.
DNA synthesis was also determined as a marker of cell
proliferation, using the BrdU incorporation and the [3H]-
thymidine uptake assays. The BrdU incorporation assay
was performed using the commercial ELISA kit, fol-
lowing the manufacturer’s instructions after incubation
with BrdU for 4 hours. To measure the uptake of [3H]-
thymidine by cells, 1 lCi of [3H]-thymidine was added to
each well and the cells were incubated for an additional
24 hours. After washing with Hepes-buffered saline, the
cells were harvested by digestion with trypsin and trans-
ferred to 5 mL of scintillation fluid. The radioactivity was
determined in a liquid scintillation counter. The results
are presented as counts per minute (CPM).
Statistical analysis
For each assay, the replicate values of three to nine sam-
ples in the experiment on a given day were first averaged.
The percent inhibition was then calculated as the percent
decrease from the corresponding value with no radia-
tion at the same time point in the same experiment. The
mean ± SD of the values from experiments performed
on different days was then calculated. Differences among
the effect of various doses of radiation and differences be-
tween aortic and venous cells were evaluated by analysis
of variance (ANOVA) with Bonferroni correction and
t test.
RESULTS
Cell counting assay
Cell counts in the control (no radiation) and most of
the radiation doses increased with time after radiation
and appeared to reach a plateau at 15 days (Fig. 1A and
B). The increase in the cell number for both aortic and
venous SMCs, however, was inhibited by radiation in a
dose-dependent manner. At 10 days post-irradiation, the
number of cells was significantly (P < 0.01) lower at doses
≥5 Gy for aortic cells and ≥10 Gy for venous cells, com-
pared to control. At all doses, the aortic cells were more
sensitive to radiation than the venous cells; the percent
inhibition was significantly greater (P < 0.01) at 20 Gy
and 50 Gy (Fig. 1C).
MTT reduction assay
In the MTT assay, the absorbance (mitochondrial de-
hydrogenase activity) for both aortic and venous cells
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Fig. 1. Cell counting assay. (A) Effect of various doses of radiation on
the number of aortic smooth muscle cells (SMCs). Presented are mean
± SD for each data point (N = 3 separate experiments). There was a
dose-dependent inhibition of the increase in cell number by radiation.
(B) Effect of various doses of radiation on the number of venous SMCs.
Presented are mean ± SD for each data point (N = 3 separate exper-
iments). There was a dose-dependent inhibition of the increase in cell
number by radiation. (C) Comparison between aortic and venous cells
in response to various doses of radiation. Presented are % inhibition
compared to control (no radiation) at 10 days post-irradiation. ∗P <
0.01 vs. the corresponding control; ∗∗P < 0.01 vs. venous cells with the
same dose of radiation.
increased with time and reached a plateau or began to
decrease at 10 days after irradiation (Fig. 2A and B). The
increase in the mitochondrial activity of both cell types
was inhibited by radiation in a dose-dependent manner.
At 10 days post-irradiation, the activity was significantly
(P < 0.01) lower at doses ≥5 Gy in aortic cells and ≥10
Gy in venous cells. At 10 Gy and 50 Gy, the percent inhi-
bition in aortic cells was greater than that in venous cells
(Fig. 2C), but the differences were only marginally signif-
icant (P = 0.042 and 0.059, respectively).
BrdU incorporation assay
The BrdU assay also showed that the DNA synthesis in
both aortic and venous cells was inhibited by radiation in
a dose-dependent manner, although the time-dependent
pattern of response varied substantially depending on the
dose (Fig. 3A and B). With no radiation or low-dose radi-
ation (1 Gy or 5 Gy), the BrdU incorporation curves for
aortic cells were multiphasic, but the direction of change
always paralleled each other among the three dose groups
(no radiation, 1 Gy, and 5 Gy). At higher radiation doses
(≥10 Gy), the level of BrdU incorporation was rather
constant over time (Fig. 3A).
In the venous cells, the BrdU incorporation curves
were also multiphasic with no or 1 Gy radiation, but there
was a general downward trend with time. Again, the di-
rection of change paralleled each other for no radiation
and 1 Gy (Fig. 3B). At higher doses of radiation (≥5 Gy),
the time-dependent curves of BrdU incorporation were
consistently biphasic.
At 10 days post-irradiation, proliferation was signifi-
cantly (P < 0.01) inhibited at all doses ≥1 Gy for aortic
cells and at all doses ≥10 Gy for venous cells. At all doses,
the aortic cells were more sensitive to radiation than
the venous cells; the percent inhibition was consistently
and significantly greater in the aortic cells (P < 0.01)
(Fig. 3C).
[3H]-thymidine uptake assay
The thymidine uptake assay in the aortic cells (Fig. 4A)
showed time-dependent patterns of response similar to
those in the BrdU incorporation assay. For the venous
cells, however, the time-dependent patterns in the thymi-
dine uptake assay were somewhat different than those
in the BrdU assay. Despite this apparent difference, the
thymidine assay also showed that DNA synthesis in both
aortic and venous cells was consistently inhibited by ra-
diation in a dose-dependent manner. Further, at 10 days
post-irradiation, the percent inhibition in the aortic cells
was significantly greater than that in the venous cells at
10 Gy and 20 Gy (P < 0.01) (Fig. 4C).
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Fig. 2. Methylthiazoletetrazolium (MTT) assay. (A) Effect of various
doses of radiation on the mitochondrial activity of aortic smooth mus-
cle cells (SMCs). Presented are mean ± SD for each data point (N =
5 separate experiments). There was a dose-dependent inhibition of the
increase in mitochondrial activity by radiation. (B) Effect of various
doses of radiation on the mitochondrial activity of venous SMCs. Pre-
sented are mean ± SD for each data point (N = 4 separate experiments).
There was a dose-dependent inhibition of the increase in mitochondrial
activity by radiation. (C) Comparison between aortic and venous cells
in response to various doses of radiation. Presented are% inhibition
compared to control (no radiation) at 10 days post-irradiation. ∗P <
0.01 vs. the corresponding control; ∗∗P < 0.01 vs. venous cells with the
same dose of radiation. Note the difference in the scale of the vertical
axis between (A) and (B).
DISCUSSION
Since balloon angioplasty accelerates the formation of
myointimal hyperplasia, the development of strategies to
prevent hyperplasia in synthetic arteriovenous grafts is
urgently needed. Animal models suggest that both local
drug delivery [20] and external radiation [21] are promis-
ing strategies for this purpose.
In the present study, we have demonstrated that, while
external beam c radiation was effective in inhibiting the
proliferation of both human aortic and venous SMCs in
culture, the venous cells were consistently less suscepti-
ble to radiation than the aortic cells. Four different as-
says were performed to assess the effects of radiation:
cell count, MTT dye reduction, BrdU-labeled DNA up-
take, and [3H]-thymidine incorporation assays. The MTT
dye reduction assay measures the cleavage of the tetra-
zolium salt MTT into formazan by the mitochondrial
enzyme succinate dehydrogenase in living cells [18, 19].
Traditionally, cell proliferation has been assessed using
the incorporation of thymidine as an indicator of DNA
synthesis. The BrdU-labeled DNA colorimetric ELISA
[22] is based on the incorporation of the pyrimidine ana-
logue BrdU instead of thymidine into the DNA of pro-
liferating cells, and is simple, fast, and sensitive. In the
current study, the thymidine and BrdU assays showed
rather similar results. The similar chronologic pattern
of response in the aortic cells between the two assays
(Figs. 3A and 4A) and the similar chronologic pattern in
the venous cells between the two assays (Figs. 3B and 4B)
add credence to the results.
The results from the thymidine and BrdU assays were
nonetheless different from those in the cell count and
MTT reduction assays, suggesting these assays comple-
ment each other in the assessment of cellular activities
and their responses to radiation. For example, although
the venous cells were still incorporating thymidine af-
ter an extensive period of time, the rate of incorporation
began to decline after day 2 (Fig. 4B). It should be em-
phasized that this observation does not imply that these
cells were dying at this stage; in fact, they continued to
synthesize DNA, albeit at a slower rate. This decline in
DNA synthesis was nonetheless eventually manifested
by no further increase in the number of cells at a later
time point (day 15) (Fig. 1B). In contrast, the MTT re-
duction assay assesses the mitochondrial activity of the
cells, regardless of the cell number and whether the cells
are actively proliferating or not. The trend of the changes
in the MTT assay (Fig. 2A and B) in general paralleled
that for the cell counts (Fig. 1A and B), although the MTT
reduction began to decline at day 10 (Fig. 2B) while the
cell counts were still increasing (Fig. 1B). This latter ob-
servation suggests that the mitochondrial activity was less
active in the cells at days 10 to 20 compared to the ear-
lier time points. In both cell counting and MTT assays,
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Fig. 3. Bromodeoxyuridine (BrdU) assay. (A) Effect of various doses
of radiation on the proliferation of aortic smooth muscle cells (SMCs).
Presented are mean ± SD for each data point (N = 5 separate experi-
ments). Although the time-dependent profile of BrdU incorporation
varied among the groups exposed to different doses of radiation, there
was a dose-dependent inhibition of cell proliferation by radiation. (B)
Effect of various doses of radiation on the proliferation of venous SMCs.
Presented are mean ± SD for each data point (N = 4 separate experi-
ments). Although the time-dependent profiles of BrdU incorporation
there was a delay for the cells to reach confluence that
is dependent on the dose of radiation. A similar inability
of human aortic SMCs to reach confluence after a single
dose of 6 Gy radiation has been reported [23].
The control group (no radiation) displayed multipha-
sic patterns in both thymidine and BrdU assays, indicat-
ing that, while the cells continued to grow at all time,
the rate of growth changed during the course of the ex-
periments (Figs. 3 and 4). The discrepancies in results
between assays that assess thymidine incorporation and
mitochondrial activities have been previously reported
by other investigators. For example, Buttke, McCubrey,
and Owen [19] compared thymidine incorporation assay
to a tetrazolium dye reduction assay using an interleukin
(IL)-3–dependent FDC-P1 cell line. In that study, thymi-
dine uptake decreased in day 2, while the mitochondrial
activity was still increasing.
The most important finding of the present study was
the lower susceptibility of venous SMCs to radiation in
all assays examined, compared to aortic SMCs. This ob-
servation represents a distinct contrast to our earlier stud-
ies which showed that cultured human venous SMCs
were more, rather than less, susceptible to pharmaco-
logic inhibition than aortic SMCs [17]. The SMCs used in
the present study were derived from multiple passages.
Therefore, the differences observed between the aortic
and venous SMCs could potentially be due to differences
in the changes in characteristics that occurred during in
vitro culture. An alternative explanation of the differ-
ences between aortic and saphenous venous cells may
be related to the size and location of the blood vessels
from which the SMCs were obtained, instead of differ-
ences between the arterial and venous trees. It should
be emphasized that we used the same batches of SMCs
and similar passages in both the drug studies [17] and the
present radiation studies. Yet, the susceptibility of aortic
SMCs to radiation relative to venous SMCs was in the op-
posite direction as their susceptibility to drugs relative to
venous SMCs. These observations strongly suggest that
human aortic SMCs and venous cells are inherently dif-
ferent from each other. It should be emphasized that our
results were obtained in vitro and may be different from
the behavior of SMCs in vivo.
The mechanisms by which sublethal doses of radiation
inhibit the proliferation of SMCs are not fully under-
stood. Some studies have shown that radiation arrested
varied among the groups exposed to different doses of radiation, there
was a dose-dependent inhibition of cell proliferation by radiation. (C)
Comparison between aortic and venous cells in response to various
doses of radiation. Presented are% inhibition compared to control (no
radiation) at 10 days post-irradiation. ∗P < 0.01 vs. the corresponding
control; ∗∗P < 0.01 vs. venous cells with the same dose of radiation.
Note the difference in the scale of the vertical axis between (A) and
(B).
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Fig. 4. [3H]-thymidine uptake assay. (A) Effect of various doses of
radiation on the proliferation of aortic smooth muscle cells (SMCs).
Presented are mean ± SD for each data point (N = 3 separate experi-
ments). There was a dose-dependent inhibition of cell proliferation by
radiation. (B) Effect of various doses of radiation on the proliferation
of venous SMCs. Presented are mean ± SD for each data point (N =
3 separate experiments). There was a dose-dependent inhibition of cell
proliferation by radiation. (C) Comparison between aortic and venous
cells in response to various doses of radiation. Presented are% inhibi-
tion compared to control (no radiation) at 10 days post-irradiation. ∗P
< 0.01 vs. the corresponding control; ∗∗P < 0.01 vs. venous cells with the
same dose of radiation. Note the difference in the scale of the vertical
axis between (A) and (B).
cell cycles at the G2/M phase [9, 24], while others showed
that the arrest occurred at the transition between the G1/S
and G2/M phases [25] or at both the G0/G1 and G2 phases
[6]. Recently, Scott et al [12] reported a G0/G1 block in
rat aortic and human coronary artery SMCs at 24 hours
after radiation, but an S phase arrest by 48 hours and a
G2/M phase arrest by 96 hours after radiation. Thus, the
point of arrest within the cell cycle appears to depend on
the time of examination after irradiation.
In various cell types, radiation can also induce apop-
tosis and subsequent cell death [6, 26]. It is, however,
unlikely that apoptosis plays a significant role in the inhi-
bition of SMC proliferation by radiation [10]. In prior
studies of rat aortic [8] and human coronary arterial
[12] SMCs, there was no increase in DNA laddering and
proteolytic adenosine diphosphate (ADP)-ribose poly-
merase (PARP) cleavage was not detected in irradiated
rat aortic SMCs [10]. Further, terminal deoxynucleotidyl
transferase (TdT)-mediated deoxyuridine triphosphate
(dUTP) biotin nick end labeling (TUNEL) was not in-
creased in the arterial wall of porcine coronary artery
after irradiation [27]. Additional studies will be needed
to explore the mechanisms by which radiation inhibits
the proliferation of vascular SMCs and the mechanisms
underlying the different responses between aortic and
venous SMCs. Perhaps even more intriguing are the cel-
lular mechanisms that allow one type of SMC to be more
responsive to radiation and another type of SMC to be
more responsive to pharmacologic agents.
A recent in vivo study is of particular relevance to
the present findings. Kelly et al [21] employed a porcine
model of synthetic arteriovenous dialysis grafts and
showed that external beam radiation applied immedi-
ately after placement of the graft reduced the percent-
age of luminal stenosis by 47% (P = 0.051) in the treated
arteries and by 23% (P = 0.039) in the treated veins.
These data were interpreted by the authors to represent
a greater effectiveness of external radiation in prevent-
ing stenosis at the arterial anastomosis than at the venous
anastomosis. They also appear to be consistent with the
present study showing a greater responsiveness of cul-
tured aortic SMCs to c radiation compared to venous
cells.
CONCLUSION
The present results showed that external beam c radi-
ation was effective in inhibiting the proliferation and mi-
tochondrial enzymatic activity of both human aortic and
venous SMCs in culture; however, the venous cells were
less susceptible to radiation than the aortic cells. There-
fore, the effective radiation dosages used in vivo likely
vary depending on the target location. Future strategies
using radiation to prevent stenosis in hemodialysis vascu-
lar access and other vessels should take these differences
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into consideration. Further investigations are needed to
determine the mechanisms by which various vascular
SMCs types respond differently to antiproliferative drugs
and radiation.
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